NEW YORK, NY, UNITED STATES, January 6, 2026 / EINPresswire.com / — Panther Life Sciences announces expanded access to its ...

As they prepare for the J.P. Morgan Healthcare Conference next week, biotech leaders and analysts say companies are better ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital ...

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th ...

If you are a Class 12 science student, chances are you have come across this question more than once. Should you choose ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

Europe needs a new system compelling researchers, governments and companies to share risk from the earliest stages of therapy ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

The TIGIT inhibitors market is poised for growth with the anticipated drug approval by 2030, over 40 drugs in clinical trials, and a dynamic landscape involving major pharmaceutical and biotech firms.

Nizwa: A landmark research project on the development of a 3D-bioprinted wound dressing in the health sector has secured ...

A life-sciences job in Boston used to be a sure path to a high-paying career, but empty labs and unemployed grads now herald ...